Botox may take ten minutes. Lip filler may happen in a beautiful studio. That does not make either one less medical.¹
Dermal filler can cause complications ranging from swelling and infection to vascular occlusion. In rare cases, filler inadvertently entering a blood vessel can cause tissue necrosis, visual impairment, blindness or stroke.¹
That does not mean filler is inherently dangerous. It means the person performing the treatment needs to understand anatomy, product selection, injection technique — and what to do if something goes wrong.
The FDA itself tells patients to choose a licensed healthcare provider who is trained and experienced in injecting dermal fillers.²
Where Did Your Botox Come From?
Here is another question most patients never think to ask.
Where did the product come from?
In November 2025, the FDA issued warning letters to 18 companies for illegally marketing unapproved and misbranded botulinum toxin products. The agency specifically warned that unapproved products can carry serious health risks and noted adverse events including symptoms of botulism.³
There have also been counterfeit and unapproved dermal fillers offered in the United States.⁴
The FDA recommends that healthcare providers use FDA-approved filler products, inspect packaging for authenticity and ensure products are properly labeled and sealed.⁴
This is one reason suspiciously cheap injectable treatments should make you ask questions. The syringe may look exactly the same. What is inside it might not be.
Your Injector Should Know More Than How to Inject
Good injecting is not just knowing where to put Botox or how to make lips look pretty.
It means understanding:
Facial anatomy
Vascular anatomy
How different products behave in tissue
When not to inject
How to recognize a complication early
How to manage it
And when a patient's aesthetic request simply is not appropriate
Sometimes the best injector is the person who tells you no.
Medical Oversight Shouldn't Be a Technicality
As medical spas have exploded in popularity, the business of aesthetics has become increasingly separated from the medicine of aesthetics.
A beautiful space does not necessarily tell you much about the clinical infrastructure behind it.
Patients should feel comfortable asking:
Who is treating me?
What is their license and training?
What product are you using?
Where did it come from?
Who oversees the medical practice?
What happens if I have a complication tonight — or tomorrow?
Those are not difficult questions. And a reputable aesthetic practice should be able to answer them easily.
Pretty Is Important. Safe Is Non-Negotiable.
We built Plump around the idea that aesthetics can be approachable without pretending it is not medicine.
You can have a beautiful space. You can have fun getting Botox. You can want bigger lips simply because you like bigger lips.
But underneath all of that should be real medical infrastructure, legitimate products and providers who know what they are doing.
You probably spend more time researching a restaurant before dinner than researching the person who is about to inject your face.
Maybe that deserves to change.
Before you ask what is in the syringe, ask who is behind it.
Frequently asked
References
Published sources supporting the claims above. Peer-reviewed literature, FDA labeling and specialty society guidance only.
01Dermal filler risks including vascular occlusion and vision loss
The FDA lists filler complications from swelling and infection to vascular occlusion; in rare cases filler entering a vessel can cause tissue necrosis, visual impairment, blindness or stroke — which is why injector anatomy training matters.
U.S. Food and Drug Administration. Dermal Fillers (Soft Tissue Fillers). FDA consumer information. 2023.View sourceFDA labeling
02FDA recommendation to choose a trained, experienced licensed healthcare provider
The FDA explicitly advises patients to select a licensed healthcare provider who is trained and experienced in dermal fillers — technique and clinical judgment are as important as the product itself.
U.S. Food and Drug Administration. Dermal Fillers (Soft Tissue Fillers). FDA consumer information. 2023.View sourceFDA labeling
03FDA warning letters for unapproved and misbranded botulinum toxin products
In November 2025 the FDA warned 18 companies for illegally marketing unapproved botulinum toxin products and noted adverse events including symptoms of botulism — a reminder that not every syringe contains what it claims.
U.S. Food and Drug Administration. FDA warns 18 companies for illegally marketing unapproved and misbranded botulinum toxin products. FDA news release. 2025.View sourceFDA labeling
04Counterfeit and unapproved dermal fillers in the United States
The FDA has identified counterfeit and unapproved dermal fillers offered in the U.S., reinforcing why patients should ask about product authenticity and why suspiciously cheap treatments warrant scrutiny.
U.S. Food and Drug Administration. Dermal Fillers (Soft Tissue Fillers). FDA consumer information. 2023.View sourceFDA labeling
Medically reviewed by Alexander Blinski — last reviewed September 7, 2026.
